derinet® Schweiz
Zurück

10.50% p.a. Barrier Reverse Convertible auf Abbott Labs, Moderna, Pfizer

  • Valor 58149591
  • ISIN CH0581495915
Produkt verfallen am 09.06.2022
  • Barrierenbeobachtung am Laufzeitende
Pfizer Inc.USD 
Abbott LaboratoriesUSD 
Moderna Inc.USD 
Bitte beachten Sie, dass es sich hierbei um eine Indikation handelt.

Dokumente

Official Notice

Issuer: Vontobel Financial Products Ltd., DIFC Dubai
Product: 10.50% p.a. Barrier Reverse Convertible on Abbott Labs, Moderna, Pfizer
CH-Sec.No 58149591
ISIN: CH0581495915

Facts:
Changes regarding guarantor of the derivatives

Issuer:
Vontobel Financial Products Ltd., DIFC Dubai (Vontobel Holding AG as guarantor)

As of 13 July 2021 the rating agency Moody’s amended the long-term issuer rating of Vontobel Holding AG, Zurich to A2 (new) from A3 (old).

Further information and details about these news ratings and changes are available on the Vontobel website https://www.vontobel.com/en-ch/about-vontobel/investor-relations/credit-ratings/.

Date: 16 July 2021
Bank: Bank Vontobel AG
Person: Issuance CH-APAC
Phone: +41 58 283 78 75
E-Mail: IssuanceCH-APAC@vontobel.com
ArtDatumTitel
Notice16.07.2021Changes regarding guarantor of the derivatives